Press Release - October 10, 2022
​
Ceres Nanosciences Launches New Nanotrap Microbiome Particles
​
MANASSAS, Virginia — October 10, 2022 – Ceres Nanosciences (Ceres) today announced the launch of two new products, Nanotrap Microbiome B Particles and Nanotrap Enhancement Reagent 3. Labs around the world are already using Nanotrap particles to capture and concentrate microbes from samples like wastewater, saliva, and transport medium. The new products launched today will enable those customers to expand the range of microbes that can be captured and concentrated.
​
Today’s product launch occurred at WEFTEC 2022, where Ceres also released an application note demonstrating that the Nanotrap Microbiome B Particles can capture and concentrate Escherichia coli, Salmonella enterica, Campylobacter jejuni, Listeria monocytogenes, Clostridioides difficile, and crAssphage from wastewater.
​
Tomorrow, there will be a presentation describing how one of Ceres’ customers uses the Nanotrap Microbiome Particles in a single workflow to simplify wastewater monitoring for viruses, bacteria, and parasites across dozens of sites in Bangladesh.
Ceres' Nanotrap Microbiome Particles
Nanotrap Microbiome Particles enable manual or automated methods that eliminate time consuming filtration, centrifugation, and bead-beating steps. Nanotrap Microbiome Particles are compatible with multiple sample types, nucleic acid extraction kits, and downstream analysis techniques, ensuring simple and easy integration into a laboratory’s workflow. As part of this product line expansion, the Nanotrap Magnetic Virus Particles have been renamed to Nanotrap Microbiome A Particles.
“We have customers all over the world who have had great success using the Nanotrap Microbiome A Particles to capture and concentrate viruses like SARS-CoV-2, influenza, RSV, and monkeypox virus from clinical or environmental samples,” said Ben Lepene, Ceres Nanosciences CTO. “But we’ve also heard that there are some microbes that are harder to capture, and I am really excited to see what our customers can do with these new Nanotrap Microbiome B Particles.”
​
***
​
​
About Ceres Nanosciences, Inc.
Ceres Nanosciences is a privately held company, located in Prince William County, Virginia, focused on incorporating its novel Nanotrap® particle technology into a range of diagnostic and research products and workflows. The Nanotrap® particle technology can improve diagnostic testing by capturing, concentrating, and preserving low abundance analytes from biological samples. The Nanotrap® particle technology was developed with support from the National Institutes of Health, the Defense Advanced Research Projects Agency, the Bill and Melinda Gates Foundation, Schmidt Futures, the Defense Threat Reduction Agency, and the Commonwealth of Virginia. Learn more, including how Ceres is partnering with leading life science, bio-pharmaceutical, and diagnostic companies at www.ceresnano.com.
Press Contact:
Ross M. Dunlap
Ceres Nanosciences, Inc
1.800.615.0418 ext. 202
​
​